The Food and Drug Administration is considering adding warning labels to antidepressants for women who are pregnant, despite ...

On Monday morning, the FDA hosted a 10-person expert panel on the use during pregnancy of SSRIs, which include medications ...

Members of an advisory panel have proposed adding warning labels to some medication about adverse maternal and fetal risks in ...

Democrats have accused Robert Kennedy Jr. of making claims without scientific research to back them and say his claims are ...

A Food and Drug Administration panel discussing the use of antidepressants during pregnancy Monday largely amounted to ...

Obstetricians and psychiatrists are concerned about a recent FDA panel spreading misinformation about the potential harms of using SSRIs during pregnancy and postpartum.

One panelist, Roger McFillin, a clinical psychologist, wondered aloud if women are “just naturally experiencing their ...

An FDA panel meeting featured a heated dialogue over whether fluoride supplements could pose health risks to children. Here's ...

An FDA advisory panel concludes that the efficacy of brexpiprazole, when started concurrently with sertraline, has not been ...

Most Oncologic Drugs Advisory Committee members took issue with the lack of dosing optimization and the lack of US patient ...

NBC News medical contributor Dr. Natalie Azar reports on the FDA panel discussion of the use of antidepressants during ...